Apr 9, 2021 0 9
Apr 9, 2021 0 8
Biotech
Previous Article
Next Article
Mar 13, 2020 0 479
Apr 23, 2020 0 143
May 1, 2020 0 149
Apr 27, 2020 0 135
Apr 15, 2020 0 170
Mar 28, 2020 0 293
Apr 10, 2020 0 29
Mar 6, 2020 0 23
Mar 25, 2020 0 18
Mar 17, 2020 0 17
Mar 13, 2020 0 16
Mar 13, 2020 0 405
Jun 2, 2020 0 114
Apr 3, 2020 0 152
Like other drugmakers, the companies will screen antibodies from recovered COVID-19...
Apr 11, 2020 0 137
Apr 30, 2020 0 137
May 6, 2020 0 136
University of Illinois classics professor Clara Bosak-Schroeder writes about how...
Apr 28, 2020 0 140
In a boost to the companies' come-from-behind immunotherapy bid, their drug Libtayo...
Apr 14, 2020 0 140
Credit: West Virginia University A new chemical compound created by researchers...
May 7, 2020 0 136
Credit: Vanderbilt University Medical Center Unplanned extubations in adult and...
Apr 28, 2020 0 139
Compass Pathways has raised $80 million to prepare its psilocybin therapy for phase...
Apr 21, 2020 0 133
The FDA OK for Tukysa comes four months early and gives the biotech, which has seen...
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.